CRIS Current Research Information System

CARACENI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.861
EU - Europa 9.315
AS - Asia 4.795
AF - Africa 503
SA - Sud America 42
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 7
Totale 26.538
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.829
IT - Italia 2.562
GB - Regno Unito 2.023
CN - Cina 1.560
VN - Vietnam 1.235
SG - Singapore 1.219
SE - Svezia 1.168
DE - Germania 1.014
IN - India 452
UA - Ucraina 409
FR - Francia 361
IE - Irlanda 346
RU - Federazione Russa 345
CH - Svizzera 275
BG - Bulgaria 229
TG - Togo 221
ZA - Sudafrica 159
EE - Estonia 157
JO - Giordania 108
FI - Finlandia 99
CI - Costa d'Avorio 70
ES - Italia 63
NL - Olanda 62
IR - Iran 61
BE - Belgio 46
HK - Hong Kong 37
AT - Austria 33
JP - Giappone 31
ID - Indonesia 30
CA - Canada 28
GR - Grecia 26
HR - Croazia 25
SC - Seychelles 23
NG - Nigeria 20
CL - Cile 15
CZ - Repubblica Ceca 13
BR - Brasile 12
AU - Australia 11
RO - Romania 11
LB - Libano 10
TR - Turchia 10
PL - Polonia 9
PT - Portogallo 9
UZ - Uzbekistan 8
EC - Ecuador 7
EU - Europa 6
AL - Albania 5
EG - Egitto 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
IL - Israele 4
NZ - Nuova Zelanda 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
BO - Bolivia 3
DK - Danimarca 3
MK - Macedonia 3
MY - Malesia 3
RS - Serbia 3
BD - Bangladesh 2
KR - Corea 2
KZ - Kazakistan 2
LT - Lituania 2
LU - Lussemburgo 2
MX - Messico 2
NO - Norvegia 2
PK - Pakistan 2
SA - Arabia Saudita 2
SI - Slovenia 2
TN - Tunisia 2
VA - Santa Sede (Città del Vaticano) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CG - Congo 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MN - Mongolia 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
VE - Venezuela 1
Totale 26.538
Salva come PNG Salva come JPEG
Città #
Southend 1.824
Fairfield 1.433
Chandler 1.137
Singapore 1.065
Ashburn 855
Dong Ket 773
Woodbridge 717
Santa Clara 697
Wilmington 640
Seattle 613
Houston 591
Cambridge 547
Princeton 493
Bologna 438
Boardman 357
Ann Arbor 352
Dublin 344
Bern 247
Jacksonville 226
Sofia 226
Lomé 221
Nanjing 191
Westminster 187
Padova 175
Milan 161
Berlin 143
Amman 108
Shenyang 107
Jinan 104
Saint Petersburg 97
Beijing 96
Rome 96
San Diego 91
Florence 83
New York 83
Turin 83
Helsinki 81
Redmond 77
Abidjan 70
Changsha 65
Medford 64
Nanchang 58
Mülheim 55
Hebei 54
Dearborn 52
Shanghai 50
Guangzhou 48
Bremen 47
Jiaxing 42
Redwood City 41
Tianjin 41
Brussels 39
Zhengzhou 35
Ningbo 34
Des Moines 33
Falls Church 33
Los Angeles 33
Hong Kong 30
Norwalk 30
Olalla 30
Paris 30
Jakarta 28
Ardabil 27
Grafing 27
Hangzhou 26
Barcelona 23
Mahé 22
Tokyo 21
Chicago 20
Haikou 20
Mountain View 20
Abeokuta 19
Aversa 19
Falkenstein 19
Fremont 19
Fuzhou 19
Kunming 19
Modena 19
Washington 19
Lanzhou 18
Taizhou 18
Vienna 18
Moscow 17
Phoenix 17
Shenzhen 17
Taiyuan 17
Verona 17
Amsterdam 16
Lappeenranta 16
London 16
Munich 16
Boydton 15
Cesena 15
Zanjan 15
Bari 14
Faenza 14
Nuremberg 14
Parma 14
Toronto 14
Wuhan 14
Totale 17.491
Salva come PNG Salva come JPEG
Nome #
L’arterializzazione della vena porta per insuffcienza epatica acuta 540
Arterializzazione della vena porta per il trattamento dell’insufficenza epatica acuta secondaria ad estesa resezione epatica nel ratto. 412
Le alterazioni dell’emodinamica sistemica e distrettuale come fattori patogenetici nella cirrosi scompensata. 257
Accesses for alcohol intoxication to the emergency department and the risk of re-hospitalization: An observational retrospective study 219
L’albumina nelle malattie del fegato. 204
A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. 189
A novel model of CCl4-induced cirrosi with ascites in the mouse. 188
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 187
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 185
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 183
Acute Liver Failure Caused by Amanita phalloides Poisoning 182
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 182
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 178
569 ENDOCANNABINOIDS AND CIRRHOSIS: HAVE WE PICKED THE RIGHT ONE? 170
A case of pneumonia and sepsis in cirrhosis as paradigm of the problems in the management of bacterial infections in cirrhosis and of the limitations of current knowledge 166
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 166
null 164
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 161
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 159
Dossier Epatologia: Sindrome epatopolmonare e ipertensione portopolmonare. 158
A new liver extracorporeal device (LEONARDO) to treat swine with post-resection acute liver failure 155
Portal vein arterialization in a patient with acute liver failure 153
A novel sodium overload test predicting ascites decompensation in rats with CCL4-induced cirrhosis. 152
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma 151
Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. 150
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. 149
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 149
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 148
Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients? 148
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 148
Insufficienza epatica acuta ed epatite subacuta. 147
The nutritional status modulates preservation-reperfusion injury in rat fatty liver. 145
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 145
Linee-guida per l’uso clinico dell’albumina: l’esperienza del Policlinico S. Orsola-Mallpighi di Bologna. 145
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 145
The reduced tolerance of rat fatty liver to ischemia-reperfusion is associated to mitochondrial oxidative injury. 144
First report of fulminant hepatic failure treated with portal v ein arterialization avoiding liver transplantation 144
Clinical indications for the albumin use: Still a controversial issue. 144
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 143
Cardiac electrophysiological abnormalities in patients with cirrhosis. 142
null 142
Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function. 141
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database 140
Monofocal hepatocellular carcinoma: How much does size matter? 140
Soluble Receptor Activator of Nuclear Factor-kB Ligand (sRANKL)/Osteoprotegerin balance in ageing and age-associated diseases. 139
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 139
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF 139
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 138
null 138
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts. 138
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 138
Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. 137
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe 137
A case of prolonged cholestatic hepatitis induced by azithromycin in a young woman 136
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 135
Portal vein arterialization for the treatment of post resection acute liver failure in the rat. 135
Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. 134
Successful treatment of CCl4-induced acute liver failure with portal vein arterialization in the rat. 134
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 134
CCL4-induced acute liver failure with portal vein arterialization in the rat 133
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 133
Hyperoxia fully protects mitochondria of explanted livers 132
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 132
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 130
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 129
Long-term treatment of hepatorenal syndrome as a bridge to liver transplantation. 129
How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. 129
The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain 129
Metabolic disorders across hepatocellular carcinoma in Italy 128
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. 127
The analysis of food intake in patients with cirrhosis waiting for liver transplantation: A neglected step in the nutritional assessment 126
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival. 126
The endocannabinoid system and liver diseases. 125
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 124
Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. 124
CCL4-Induced acute liver failure with portal vein arterialization in the rat 124
First report of fulminant hepatic failure treated with portal vein arterialization avoiding liver transplantation 123
Consensus conference on TIPS management: Techniques, indications, contraindications 122
Complicanze della cirrosi epatica: le infezioni batteriche. 121
Simple and rapid LC-MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress 121
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 120
Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial 120
Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. 119
Portal vein arterialization: a new surgical option against acute liver failure? 119
C-type natriuretic peptide (CNP) favours natriuresis in pre-ascitic cirrhotic patients. 118
Dorsal acoustic windows may ameliorate liver ultrasound in patients with liver disease and meteorism/obesity/ascites. 118
Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 118
Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis 118
null 117
Molecular and functional characterization of CD133+stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 117
Terapia cellulare in Epatologia 115
QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. 115
AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis 115
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 115
null 115
AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis. 115
Portal vein arterialization increases liver regeneration in acute liver failure induced by extended hepatectomy or toxin administration in the rat 114
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 114
Development and validation of a prognostic score to predict mortality in patients with acute on chronic liver failure. 114
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 114
Totale 14.808
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.633
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.633
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.055 0 0 0 0 0 0 691 710 756 363 215 320
2020/20213.838 595 234 106 206 88 171 114 224 356 205 166 1.373
2021/20224.776 410 158 317 369 405 248 155 391 186 274 1.163 700
2022/20235.219 505 753 284 601 321 429 177 294 864 167 402 422
2023/20241.931 122 265 119 190 122 386 112 145 72 143 158 97
2024/20253.948 295 993 570 557 1.063 382 88 0 0 0 0 0
Totale 27.264